Page last updated: 2024-09-04

cositecan and Brain Neoplasms

cositecan has been researched along with Brain Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batchelor, T; Carson, KA; Grossman, SA; Hausheer, F; Lesser, G; Nabors, LB; Peereboom, D; Phuphanich, S; Supko, JG1
Bigner, DD; Friedman, HS; Hausheer, F; Keir, ST; Lawless, AA1

Trials

1 trial(s) available for cositecan and Brain Neoplasms

ArticleYear
Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.
    Neuro-oncology, 2008, Volume: 10, Issue:4

    Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Camptothecin; Drug Interactions; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local

2008

Other Studies

1 other study(ies) available for cositecan and Brain Neoplasms

ArticleYear
Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice.
    Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Female; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous

2001